We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
Cap. Flow
+$281M
Cap. Flow %
7.02%
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$104M
2
AAPL icon
Apple
AAPL
+$60.7M
3
AMZN icon
Amazon
AMZN
+$47.5M
4
AXP icon
American Express
AXP
+$28.7M
5
TRV icon
Travelers Companies
TRV
+$27.2M

Top Sells

Rank Stock Value
1
FSLR icon
First Solar
FSLR
+$28.1M
2
JNJ icon
Johnson & Johnson
JNJ
+$28.1M
3
CLX icon
Clorox
CLX
+$26.2M
4
TJX icon
TJX Companies
TJX
+$24.8M
5
MCK icon
McKesson
MCK
+$23.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.39%
2 Financials 11.87%
3 Technology 10.68%
4 Communication Services 10.67%
5 Consumer Discretionary 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPXX
326
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$1.81M 0.05%
+165,000
New +$541K
MACK
327
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$1.81M 0.05%
27,581
-1,703
-6% -$88.9K
RCI icon
328
Rogers Communications
RCI
$17.7B
$1.78M 0.04%
44,643
+1,994
+5% +$72.2K
CI icon
329
Cigna
CI
$76.6B
$1.77M 0.04%
12,994
-21,114
-62% -$2.9M
CAG icon
330
Conagra Brands
CAG
$7.07B
$1.77M 0.04%
51,215
-4,517
-8% -$147K
NOC icon
331
Northrop Grumman
NOC
$77B
$1.77M 0.04%
8,973
+555
+7% +$105K
IMGN
332
DELISTED
Immunogen Inc
IMGN
$1.76M 0.04%
208,000
-30,100
-13% -$255K
TGTX icon
333
TG Therapeutics
TGTX
$8.58B
$1.75M 0.04%
207,000
-29,200
-12% -$256K
HRB icon
334
H&R Block
HRB
$5.18B
$1.75M 0.04%
+66,665
New +$2.09M
HAL icon
335
Halliburton
HAL
$27.9B
$1.75M 0.04%
49,230
+10,900
+28% +$356K
RTN
336
DELISTED
Raytheon Company
RTN
$1.74M 0.04%
14,272
+614
+4% +$75.6K
ITW icon
337
Illinois Tool Works
ITW
$81.4B
$1.73M 0.04%
16,929
+1,665
+11% +$154K
PGR icon
338
Progressive
PGR
$124B
$1.72M 0.04%
49,095
-89,764
-65% -$2.87M
KPTI icon
339
Karyopharm Therapeutics
KPTI
$168M
$1.66M 0.04%
12,467
-273
-2% -$30.1K
MFC icon
340
Manulife Financial
MFC
$72.6B
$1.66M 0.04%
117,140
+409
+0.4% +$5.48K
FAST icon
341
Fastenal
FAST
$54B
$1.63M 0.04%
134,148
-823,036
-86% -$8.95M
RXDX
342
DELISTED
Ignyta, Inc.
RXDX
$1.62M 0.04%
240,000
-27,500
-10% -$226K
AGIO icon
343
Agios Pharmaceuticals
AGIO
$2.16B
$1.61M 0.04%
40,000
-6,600
-14% -$282K
EBAY icon
344
eBay
EBAY
$48.6B
$1.61M 0.04%
67,727
-254,123
-79% -$6.18M
FSLR icon
345
First Solar
FSLR
$21.8B
$1.6M 0.04%
23,517
-418,806
-95% -$28.1M
BBWI icon
346
Bath & Body Works
BBWI
$4.01B
$1.59M 0.04%
22,471
+6,884
+44% +$494K
LVLT
347
DELISTED
Level 3 Communications Inc
LVLT
$1.59M 0.04%
30,196
+2,261
+8% +$112K
ACOR
348
DELISTED
Acorda Therapeutics
ACOR
$1.58M 0.04%
500
-183
-27% -$760K
DO
349
DELISTED
Diamond Offshore Drilling
DO
$1.56M 0.04%
72,323
-12,246
-14% -$241K
PTLA
350
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.55M 0.04%
76,500
-1,600
-2% -$50.8K
12 13
14
15 16

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2016 Portfolio in Review

As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.

  • Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
  • Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
  • Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
  • Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
  • Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
  • Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
  • Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.

Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.